The impact of the Cannabis Act (CAC) and the COVID-19 pandemic on substance-related disorders among pregnant women in Quebec.
Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee. – Biotech Investments
Spexis AG / Key word(s): Miscellaneous 22-Jul-2024 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely